Gilead Sciences (GILD) Net Margin (2009 - 2026)

Gilead Sciences has reported Net Margin for 18 years, with the latest figure at 29.04% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 931.0% year-over-year to 29.04%; the trailing twelve-month figure through Mar 2026 stood at 32.16% (up 1140.0% YoY), and the FY2025 full-year result was 28.9%, up 2724.0% from the prior year.
• Net Margin for Q1 2026 stood at 29.04%, down from 31.9% in the prior quarter.
• The five-year high for Net Margin was 39.28% in Q3 2025, with the low at 62.38% in Q1 2024.
• Historically, Net Margin has averaged 17.43% across 5 years, with a median of 22.1% in 2022.
• Annual changes were most pronounced in 2024 — Net Margin tumbled 7788 bps — and 2025, when it jumped 8211 bps.
• Gilead Sciences' Net Margin stood at 22.1% in 2022, then slipped by 10 bps to 19.9% in 2023, then advanced by 18 bps to 23.54% in 2024, then surged by 35 bps to 31.9% in 2025, then retreated by 9 bps to 29.04% in 2026.
• The last three Net Margin figures came in at 29.04% (Q1 2026), 31.9% (Q4 2025), and 39.28% (Q3 2025), per Business Quant data.